CIK 0001123494
- Non-accelerated filer
- Smaller reporting company
HARVARD BIOSCIENCE INC
Sign in to watch- Ticker
- HBIO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043306140
- Phone
- +1 508-893-8999
- Business address
- 84 OCTOBER HILL RD, HOLLISTON, MA, 01746
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-08-07 | Gagnon Robert E. Chief Financial Officer | Sale | −100,015 | $6.08 | $608K | 349,286 |
| 2018-08-07 | Gagnon Robert E. Chief Financial Officer | Exercise or conversion · Stock option (right to buy) | −30,000 | 0 | ||
| 2018-08-07 | Gagnon Robert E. Chief Financial Officer | Exercise or conversion · Stock option (right to buy) | −20,000 | 0 | ||
| 2018-08-07 | Gagnon Robert E. Chief Financial Officer | Exercise or conversion · Stock option (right to buy) | −37,500 | 12,500 | ||
| 2018-08-03 | Sun Yong VP - Commercial Operations | Shares withheld for taxes | −2,043 | $5.70 | $12K | 249,732 |
| 2018-08-03 | Gagnon Robert E. Chief Financial Officer | Shares withheld for taxes | −5,170 | $5.70 | $29K | 330,058 |
| 2018-08-03 | Duchemin Jeffrey Chief Executive Officer | Shares withheld for taxes | −12,619 | $5.70 | $72K | 742,249 |
| 2018-08-01 | Sun Yong VP - Commercial Operations | Exercise or conversion | +50,000 | $4.31 | $216K | 299,858 |
| 2018-08-01 | Sun Yong VP - Commercial Operations | Shares withheld for taxes | −41,054 | $5.75 | $236K | 258,804 |
| 2018-08-01 | Sun Yong VP - Commercial Operations | Exercise or conversion · Stock option (right to buy) | −50,000 | 50,000 | ||
| 2018-07-27 | Gagnon Robert E. Chief Financial Officer | Exercise or conversion | +30,000 | $4.31 | $129K | 404,315 |
| 2018-07-27 | Gagnon Robert E. Chief Financial Officer | Exercise or conversion | +20,000 | $4.12 | $82K | 424,315 |
| 2018-07-27 | Gagnon Robert E. Chief Financial Officer | Sale | −62,514 | $5.54 | $346K | 361,801 |
| 2018-07-27 | Gagnon Robert E. Chief Financial Officer | Exercise or conversion · Stock option (right to buy) | −30,000 | 30,000 | ||
| 2018-07-27 | Gagnon Robert E. Chief Financial Officer | Exercise or conversion · Stock option (right to buy) | −20,000 | 20,000 | ||
| 2018-07-24 | Gagnon Robert E. Chief Financial Officer | Sale | −5,570 | $5.25 | $29K | 374,315 |
| 2018-07-23 | Gagnon Robert E. Chief Financial Officer | Sale | −1,465 | $5.25 | $8K | 379,885 |
| 2018-07-19 | Gagnon Robert E. Chief Financial Officer | Sale | −1,100 | $5.25 | $6K | 381,350 |
| 2018-07-13 | Gagnon Robert E. Chief Financial Officer | Sale | −1,062 | $5.25 | $6K | 382,450 |
| 2018-07-12 | Gagnon Robert E. Chief Financial Officer | Exercise or conversion | +5,828 | $4.12 | $24K | 392,657 |
Page 15 of 17 · 324 trades